This post has expired! It was posted more than 90 days ago.
<- Back

151803 - Simplifying treatment in Type 2 diabetes

Speciality Classification
General Practice ( GP ) / Family Medicine
6 hours


This ALM has been developed to help you improve your knowledge, skills and confidence in choosing the right therapy for adults with T2D, including those with established cardiovascular disease (CVD) and/or chronic kidney disease (CKD). 

Activity 1 - Snapshot of T2D ( 45 min ) 
Activity 2 - Identification and diagnosis of T2D ( 60 min ) 
Activity 3 - Treatment goals and lifestyle modifications in T2D ( 45 min ) 
Activity 4 - Pharmacological approaches to glucose lowering ( 75 min ) 
Activity 5 - Treatment challenges ( 60 min ) 
Activity 6 - Assessing and managing CVD in adults with T2D ( 30 min ) 
Activity 7 - Assessing and managing CKD in adults with T2D ( 30 min ) 

This ALM will take approximately six (6) hours to complete.

Relevance to General Practice

Type 2 diabetes (T2D) has emerged as one of the major health threats of the 21st century. It is among the most common reasons to see a general practitioner (GP) and will become more common in the future. Undiagnosed or poorly managed T2D can lead to many long-term complications including cardiovascular disease (CVD), kidney failure, and limb amputations. Thus, early recognition and optimal management are crucial.The management of T2D is seldom straightforward, and many different factors influence the choice and intensity of therapy, including patient age, comorbidity, resources, life expectancy and the potential for benefits and risks. With this in mind, and the ongoing reporting of the results of cardiovascular outcomes safety trials, it is timely to revisit our knowledge and practices of current antidiabetic agents.

Learning outcomes
  • Implement screening protocols for asymptomatic patients according to the RACGP’s General practice management of type 2 diabetes, 2016–18 edition
  • Explain the diagnostic criteria for type 2 diabetes in conjunction with confirmatory laboratory testing
  • Outline appropriate lifestyle modifications
  • Evaluate glucose-lowering medicines as appropriate for individual clinical needs
  • Communicate the findings of cardiovascular outcomes trials of DPP-4 inhibitors to patients and colleagues
  • Delivery
    151803 - Simplifying treatment in Type 2 diabetes
    6 hours
    Start Date
    End Date
    CPD Points
    6 hours